tirzepatide vs mazdutide tirzepatide: comparing dual-agonist weight loss peptides Everyone's picking a side. 💛🆚💙

Semaglutide (aka Ozempic or Wegovy) has become ubiquitous because of established benefits in diabetes and obesity but SELECT showed that the wonder drug should be considered in those who are obese with established atherosclerotic CV disease (ASCVD.) In March of 2024 the FDA approved a new indication for Wegovy based on the SELECT trial to reduce the risk of CV death, stroke, and heart attack in adults with cardiovascular disease and either obese or overweight Lets take a look at the group SELECT enrolled to see if you or the patient in front of you is similar to those enrolled

Boost Immune System

Besides stimulating the release of GH, Sermorelin extends growth hormone highs

Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer